NSCLC patients show higher sTREM-1 serum levels than SCLC patients, but we were unable to demonstrate a correlation of sTREM-1 with distinct subtypes of NSCLC, CRP or tumor markers, and there was no association with stage, metastasis or response to chemotherapy. This evidence concerns the gene CRP and small cell lung carcinoma.